Join the 200th Anniversary Celebration

Original Article

Changes in the Transmission of Tuberculosis in New York City from 1990 to 1999

Elvin Geng, B.A., Barry Kreiswirth, Ph.D., Cynthia Driver, M.P.H., Jiehui Li, M.S., Joseph Burzynski, M.D., M.P.H., Phyllis DellaLatta, Ph.D., Angel LaPaz, B.A., and Neil W. Schluger, M.D.

N Engl J Med 2002; 346:1453-1458May 9, 2002

Abstract

Background

Over the past decade, there has been a reduction in the incidence of tuberculosis in New York City and in the United States. However, the reduction has been confined mainly to U.S.-born persons. Understanding the reasons for the lack of reduction among non–U.S.-born persons may lead to new strategies for tuberculosis control.

Methods

We performed DNA fingerprinting with the IS6110 insertion sequence of the organisms isolated from patients with culture-positive tuberculosis in northern Manhattan from 1990 to 1999. The goal was to identify the strains responsible for multiple infections, presumably through recent transmission (clusters of cases), as well as the strains found in only one patient, presumably representing reactivation of latent infection.

Results

Of 546 available isolates of Mycobacterium tuberculosis, 261 (48 percent) belonged to a cluster and 285 (52 percent) did not. In multivariate analysis, significant predictors of noncluster status included birth outside the United States (odds ratio for a strain causing a cluster among non-Hispanic foreign-born patients, 0.31; 95 percent confidence interval, 0.14 to 0.66; odds ratio among Hispanic foreign-born patients, 0.51; 95 percent confidence interval, 0.30 to 0.88), age greater than 60 years (odds ratio, 0.37), and diagnosis after 1993 (odds ratio, 0.50). All these characteristics appeared to be associated with reactivation disease rather than with tuberculosis due to recent transmission. Homelessness was associated with clustering (odds ratio, 1.78; 95 percent confidence interval, 0.99 to 3.20) and therefore with recent transmission.

Conclusions

These findings from northern Manhattan suggest that among foreign-born persons, tuberculosis is largely caused by reactivation of latent infection, whereas among U.S.-born persons, many cases result from recent transmission. Strategies for the control and elimination of tuberculosis among foreign-born persons at high risk should be directed toward the treatment of latent tuberculosis infection.

Media in This Article

Figure 3Proportion of Cases of Tuberculosis among Foreign-Born Patients Occurring in Clusters, According to the Length of Residence in the United States and the Presence or Absence of Human Immunodeficiency Virus (HIV) Infection.
Figure 2Cases of Tuberculosis among Foreign-Born and U.S.-Born Patients in New York City.
Article

Since reaching a peak of 10.5 cases per 100,000 in 1992, the incidence of tuberculosis in the United States has declined sharply, to just 5.8 cases per 100,000 in 2000.1 Molecular epidemiologic studies in cities such as San Francisco and New York indicated that 40 percent or more of tuberculosis cases resulted from recent transmission rather than from the reactivation of long-latent disease.2,3 Measures adopted by tuberculosis-control programs and hospitals with a high case load of patients with tuberculosis included improved surveillance; aggressive implementation of programs of directly observed therapy; education of physicians, aimed largely at increasing their index of suspicion with respect to tuberculosis; improving infection-control policies and practices in hospitals, jails, and prisons; and ensuring the availability of drugs to treat those with active tuberculosis.4

Nearly the entire decline in the numbers of cases of tuberculosis since 1992 is accounted for by the decline in cases among U.S.-born persons.1 By contrast, the number of cases in non–U.S.-born persons has not dropped at all but, rather, has risen slightly. More than half the cases of tuberculosis in the United States in 2000 occurred in non–U.S.-born persons. The predominance of non–U.S.-born persons among those with tuberculosis is greatest where tuberculosis case rates far exceed the national average, as in California and New York City.5

There are several possible explanations for the fact that tuberculosis-control measures have been effective in one population (U.S.-born persons) but not in another (non–U.S.-born persons).6-8 Non–U.S.-born persons may be less likely to seek medical care and therefore more likely to have undiagnosed and infectious tuberculosis for prolonged periods in their immigrant communities.9 Alternatively, some immigrants may have reactivated latent infections that were acquired in their native countries.10-12 Our tuberculosis-control measures, which are designed to interrupt transmission, would not be effective among foreign-born persons with reactivation disease.

To address the hypothesis that non–U.S.-born persons are, in general, not involved in ongoing transmission of tuberculosis and are thus relatively unaffected by current tuberculosis-control measures, we performed a molecular epidemiologic analysis of cases of tuberculosis in the Washington Heights neighborhood of New York City for the years 1990 through 1999. This neighborhood has had a tuberculosis case rate much higher than that of New York City as a whole (in excess of 125 cases per 100,000 persons in 1992, as compared with 50 per 100,000 for the city). The concentration of recent immigrants there is among the highest in the city. Over 40 percent of the residents of Washington Heights were not born in the United States.

Methods

Patient Population

Study patients included all persons with culture-proved tuberculosis who were treated at Columbia Presbyterian Medical Center between 1990 and 1999 and who resided in New York City. Columbia Presbyterian Medical Center is located in Washington Heights, a leading destination among recent immigrants to New York City, with a total of 28,824 new residents between 1990 and 1994, 82 percent of whom were from the Dominican Republic.13 Columbia Presbyterian Medical Center is the major inpatient health care provider in northern Manhattan and also provides care to many patients from adjacent Central and East Harlem, the population of which is 80 percent black and composed mostly of U.S.-born persons.

Restriction-Fragment–Length Polymorphism Analysis

Restriction-fragment–length polymorphism (RFLP) analysis (DNA fingerprinting with the IS6110 insertion sequence) was performed at the Public Health Research Institute in New York according to internationally standardized methods.14 Briefly, Mycobacterium tuberculosis DNA was extracted, digested with PvuII, subjected to electrophoresis, and hybridized by Southern blotting with a fragment of the insertion element IS6110. M. tuberculosis strains with fingerprints of five or fewer bands were subjected to secondary DNA analysis with spoligotyping (spacer oligonucleotide typing).15-17 These low-band RFLP patterns were assigned to the category of strains causing clusters of cases only if their spoligotypes were identical and specific to the IS6110 fingerprint. If they were not, they were classified as causing unique cases.

Identical strains recovered from different patients comprised a cluster of cases. Strains found in only one person were considered unique. Clustered cases were assumed to represent recent transmission, whereas a unique case was considered to result from the reactivation of latent disease. Data on clustered and unique cases were subjected to univariate and multivariate analysis; information on clinical, social, and demographic variables was obtained from the registry of the Tuberculosis Control Program at the New York City Department of Health. Study participants' addresses in New York City were mapped, and the addresses were matched to Census-block information with Topologically Integrated Geographic Encoding and Referencing system (TIGER) files, the geographic locator system of the U.S. Census. Mapping was performed with geographic-information-systems software. The study was approved by the institutional review boards of the Columbia University College of Physicians and Surgeons and the New York City Department of Health, which determined that informed consent was not required.

Statistical Analysis

In univariate analysis, chi-square tests were performed to test associations of categorical variables with cluster status. All unknown values were excluded from the analysis. The Wilcoxon test was used to test associations of continuous variables with cluster status. A marked decrease in the risk of clustering occurred for patients around the age of 60 years, and therefore age was categorized as 60 years or less or greater than 60 years. A significant drop in the risk of clustering occurred among patients in whom tuberculosis was diagnosed after 1993; therefore the year of diagnosis was analyzed as a categorical variable (1990–1993 or 1994–1999).

Variables significantly associated with cluster status (P<0.05) were entered into logistic-regression models with all unknown values represented by indicator variables. Odds ratios have been used to represent the odds of having an M. tuberculosis isolate that belonged to a cluster of isolates; that is, an odds ratio greater than 1 is associated with having a case that belongs to a cluster (presumably, a case resulting from recent transmission), and an odds ratio of less than 1 is associated with a strain's having a unique RFLP pattern (presumably, a case resulting from reactivation of latent infection). All statistical analyses were conducted with SAS software (SAS Institute, Cary, N.C.).

Results

Study Population

Of 812 cases of tuberculosis diagnosed at Columbia Presbyterian Medical Center between 1990 and 1999, 745 (91.7 percent) were culture-positive. In 575 of the 745 cases (77.2 percent), DNA analysis could also be performed. Twenty-nine patients with tuberculosis were excluded from the study either because their residence was not in New York City or because they could not be matched to the case-registry data, leaving a final study population of 546. This represented 73.3 percent of all culture-positive cases diagnosed in the study period.

Forty-six percent of the patients resided in the Washington Heights health district, and 27 percent lived in the Central and East Harlem health districts. The remainder were distributed among the Bronx (16 percent), the rest of Manhattan (7 percent), Queens (3 percent), and Brooklyn (2 percent), with one patient from Staten Island. Thirty-seven percent of the patients were born in countries other than the United States; by far the largest single group was from the Dominican Republic, making up 55.4 percent of the total foreign-born population. Forty-three percent of the patients were black, and 45 percent were Hispanic. These and other clinical and demographic characteristics are shown in Table 1Table 1Demographic, Social, and Clinical Characteristics and Their Association with Cluster Status in the Univariate Analysis.. The patients in our cohort were statistically similar to all patients in the New York City Tuberculosis Case Registry in terms of median age and age distribution, sex, human immunodeficiency virus (HIV) status, birth within or outside the United States, and the proportion of foreign-born persons who had been in the United States for up to nine years before the diagnosis of tuberculosis.

Analysis of Cluster Status

IS6110 DNA fingerprinting and spoligotyping determined that in 261 of the 546 patients (48 percent), the disease was caused by isolates that had at least one matching isolate in the cohort and that were therefore designated as belonging to a cluster. In 285 of the 546 patients (52 percent), the disease was caused by an isolate that was unique, implying reactivation of latent infection. This number included 31 patients whose isolates were “low-banders” (with five or fewer bands) and that had a match on IS6110 DNA fingerprinting but not on spoligotyping; these cases were therefore not classified as belonging to a cluster. The clusters comprised a mean of 5.2 cases (median, 3; mode, 2) and had a total of 51 distinct RFLP patterns.

On the basis of previous studies of the epidemiology of tuberculosis in which molecular techniques were used, we inferred that the cases in the clustered group represented the proportion of our study population with disease due to recent transmission. The proportion of cases caused by clustered isolates (i.e., cases of tuberculosis due to recent transmission) decreased from 63.2 percent in 1993 to 31.4 percent in 1999 (Figure 1Figure 1Linear Regression Model Showing the Relation between the Proportion of Tuberculosis Cases Occurring in Clusters (Representing Recent Transmission) and the Year of Diagnosis.). As a result, the cases of tuberculosis in northern Manhattan at the end of the study period were largely those caused by unique strains.

Risk Factors for Tuberculosis Due to Recent Transmission

Table 1 shows the odds ratios for having an isolate in the clustered rather than the unique group according to clinical, social, and demographic characteristics. Characteristics significantly associated with clustering according to the univariate analysis were male sex (odds ratio, 1.58), black race (odds ratio, 2.43), homelessness (odds ratio, 2.86), injection-drug use (odds ratio, 3.23), HIV infection (odds ratio, 1.73), and a pulmonary source of the isolate (odds ratio, 2.52). Multidrug-resistant tuberculosis, cavitary disease, and income level were not significantly associated with clustering.

In contrast, factors associated with unique RFLP patterns, representing the development of disease through reactivation of latent infection, were Asian race (odds ratio for clustering, 0.23), Hispanic ethnic background (odds ratio, 0.64), white race (odds ratio, 0.45), foreign birth (odds ratio, 0.47), diagnosis after 1993 (odds ratio, 0.52), and age of more than 60 years (odd ratio, 0.27) (Table 1).

In the multivariate analysis, birth outside the United States was strongly associated with infection with organisms not belonging to a tuberculosis cluster (Table 2Table 2Results of the Multivariate Analysis.). Both non-Hispanic foreign-born patients (odds ratio for clustering, 0.31) and Hispanic foreign-born patients (odds ratio, 0.51) were significantly less likely to be infected with an organism in a clustered group. Other characteristics found to be independently associated with the likelihood of having a unique RFLP pattern were an age of more than 60 years (odds ratio for clustering, 0.37) and diagnosis after 1993 (odds ratio, 0.50). Figure 2Figure 2Cases of Tuberculosis among Foreign-Born and U.S.-Born Patients in New York City. shows the distribution of cases among U.S.-born and foreign-born patients in northern Manhattan in 1992 and 1993 and in 1998 and 1999. In the multivariate analysis, homelessness had an odds ratio for clustering of 1.78 (95 percent confidence interval, 0.99 to 3.20).

A separate model was created to evaluate the role of predictors of clustering that were specific to foreign-born persons. Although there was no significant difference overall between the percentage of HIV-infected and non–HIV-infected foreign-born patients with organisms belonging to a tuberculosis cluster (43 percent vs. 57 percent, P=0.69), there was a significant interaction between years of residence in the United States and HIV infection. Among foreign-born persons with HIV infection, increasing length of residence in the United States was independently associated with increasing odds of clustering (odds ratio, 1.15 per year of residence; 95 percent confidence interval, 1.10 to 1.19). In contrast, among foreign-born persons without HIV infection, the opposite was found: increasing length of residence in the United States was independently associated with decreasing odds of clustering (odds ratio, 0.93; 95 percent confidence interval, 0.90 to 0.97). Thus, among persons who were born outside the United States, tuberculosis was significantly more likely to result from recent transmission among those who were HIV-infected and more likely to result from the reactivation of latent infection among those who were not infected with HIV (Figure 3Figure 3Proportion of Cases of Tuberculosis among Foreign-Born Patients Occurring in Clusters, According to the Length of Residence in the United States and the Presence or Absence of Human Immunodeficiency Virus (HIV) Infection.).

Discussion

Our study results show that over a period in which tuberculosis case rates have fallen from recent high levels, the proportion of cases occurring as a result of recent transmission dropped sharply, as manifested by the declining proportion of isolates of M. tuberculosis with RFLP patterns that matched at least one other case in the area we studied. In addition, we found that tuberculosis was unlikely to result from recent transmission in persons born outside the United States, since relatively few such persons had tuberculosis caused by an isolate that matched another in the sample. Rather, cases among foreign-born persons were substantially more likely to develop as a result of the reactivation of latent tuberculosis infection. The main exception was that HIV infection modified the effect of foreign birth and was associated with an increased likelihood of acquiring tuberculosis by recent transmission. Although our study was confined to only a part of New York City, the data are both robust and broadly applicable because of the high percentage of isolates available for IS6110 DNA fingerprinting relative to the total number of cases of tuberculosis diagnosed, the long period during which the data were collected, and the high proportion of immigrants in the neighborhoods studied. These results should have direct implications for tuberculosis-control programs in other large urban areas in the United States.1,18

During the previous decade, the number of cases of tuberculosis in New York City fell from a peak of 3811 in 1992 to 1350 in 2000, a decline of 65 percent. The causes of this rapid decline included widespread provision of medication through programs of directly observed therapy, improvements in policies and practices of infection control related to tuberculosis, and standardization of initial drug-treatment regimens for patients with active disease.4 These interventions were all aimed at curing patients with active disease quickly, which has the effect of reducing transmission in the community. Our study demonstrated that 63.2 percent of all cases belonged to a cluster in 1992, but by 1999 that figure had dropped to 31.4 percent.

Our findings provide insight into the apparent “immunity” of non–U.S.-born persons to the tuberculosis-control measures used for most of the past decade. IS6110 DNA fingerprinting of M. tuberculosis isolates from non–U.S.-born patients in the Washington Heights neighborhood of New York City demonstrates that cases in this patient population occur sporadically rather than in clusters, as a result of recent transmission. Thus, the failure of tuberculosis-control measures to decrease disease rates among non-U.S.-born persons did not occur because patients escaped these measures but, rather, because the measures used did not address the development of tuberculosis in such foreign-born persons. To decrease the prevalence of tuberculosis among non–U.S.-born persons in this country, widespread treatment of latent tuberculosis infection must be implemented. Our results support the recommendations for the treatment of latent infection in the Institute of Medicine's recent landmark report.19

The U.S. government requires that persons planning to emigrate to the United States be screened for active tuberculosis before their departure. Until recently, however, little emphasis was placed on the diagnosis and treatment of latent infection. The situation is further complicated by the generally poor acceptance and completion rates for treatment of latent tuberculosis infection.20,21 Newly revised guidelines issued by the Centers for Disease Control and Prevention, the American Thoracic Society, and the Infectious Disease Society of America encourage testing for and treatment of latent infection in persons from countries where the prevalence of tuberculosis is high who have been in the United States for less than five years.22 The recommended treatment regimen is nine months of isoniazid. A two-month regimen of rifampin and pyrazinamide has been shown to be effective in treating latent tuberculosis infection in patients with HIV infection, although there is some concern about the safety of this regimen.23 Shorter and safer regimens for the treatment of latent tuberculosis infection are urgently needed if tuberculosis is to be completely controlled and eliminated in the United States and elsewhere.

Supported in part by a grant (K24 HL04074) from the National Institutes of Health.

Source Information

From the College of Physicians and Surgeons (E.G., J.B., P.D., N.W.S.) and the Mailman School of Public Health (E.G., C.D., N.W.S.), Columbia University; the Public Health Research Institute (B.K.); and the New York City Department of Health Tuberculosis Control Program (C.D., J.L., J.B., A.L.) — all in New York.

Address reprint requests to Dr. Schluger at the Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, PH-8 Center, 622 W. 168th St., New York, NY 10032.

References

References

  1. 1

    Reported tuberculosis in the United States, 2000. Atlanta: Centers for Disease Control and Prevention, August 2001.

  2. 2

    Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994;330:1710-1716
    Full Text | Web of Science | Medline

  3. 3

    Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-1709
    Full Text | Web of Science | Medline

  4. 4

    Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City -- turning the tide. N Engl J Med 1995;333:229-233
    Full Text | Web of Science | Medline

  5. 5

    Talbot EA, Moore M, McCray E, Binkin NJ. Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA 2000;284:2894-2900
    CrossRef | Web of Science | Medline

  6. 6

    Wells CD, Ocana M, Moser K, Bergmire-Sweat D, Mohle-Boetani JC, Binkin NJ. A study of tuberculosis among foreign-born Hispanic persons in the U.S. states bordering Mexico. Am J Respir Crit Care Med 1999;159:834-837
    Web of Science | Medline

  7. 7

    Borgdorff MW, Behr MA, Nagelkerke NJ, Hopewell PC, Small PM. Transmission of tuberculosis in San Francisco and its association with immigration and ethnicity. Int J Tuberc Lung Dis 2000;4:287-294
    Web of Science | Medline

  8. 8

    Sahly HM, Adams GJ, Soini H, Teeter L, Musser JM. Epidemiologic differences between United States- and foreign-born tuberculosis patients in Houston, Texas. J Infect Dis 2001;183:461-468
    CrossRef | Web of Science | Medline

  9. 9

    Yamada S, Caballero J, Matsunaga DS, Agustin G, Magana M. Attitudes regarding tuberculosis in immigrants from the Philippines to the United States. Fam Med 1999;31:477-482
    Medline

  10. 10

    Jasmer RM, Hahn JA, Small PM, et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med 1999;130:971-978
    Web of Science | Medline

  11. 11

    Tornieporth NG, Ptachewich Y, Poltoratskaia N, et al. Tuberculosis among foreign-born persons in New York City, 1992-1994: implications for tuberculosis control. Int J Tuberc Lung Dis 1997;1:528-535
    Web of Science | Medline

  12. 12

    Chin DP, DeRiemer K, Small PM, et al. Differences in contributing factors to tuberculosis incidence in U.S.-born and foreign-born persons. Am J Respir Crit Care Med 1998;158:1797-1803
    Web of Science | Medline

  13. 13

    Lobo PA, Salvo JJ, Virgin V. The newest New Yorkers, 1990-1994: an analysis of immigration to NYC in the early 1990s. New York: Department of City Planning, 1996:298.

  14. 14

    Van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Intern Med 2001;249:1-26
    CrossRef | Web of Science | Medline

  15. 15

    Soini H, Pan X, Teeter L, Musser JM, Graviss EA. Transmission dynamics and molecular characterization of Mycobacterium tuberculosis isolates with low copy numbers of IS6110. J Clin Microbiol 2001;39:217-221
    CrossRef | Web of Science | Medline

  16. 16

    Bauer J, Andersen AB, Kremer K, Miorner H. Usefulness of spoligotyping to discriminate IS6110 low-copy number Mycobacterium tuberculosis complex strains cultured in Denmark. J Clin Microbiol 1999;37:2602-2606
    Web of Science | Medline

  17. 17

    Kremer K, van Soolingen D, Frothingham R, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 1999;37:2607-2618
    Web of Science | Medline

  18. 18

    Reported tuberculosis in the United States, 1999. Atlanta: Centers for Disease Control and Prevention, August 2000.

  19. 19

    Geiter L, ed. Ending neglect: the elimination of tuberculosis in the United States. Washington, D.C.: National Academy Press, 2000:292.

  20. 20

    Snider DE Jr, Farer LS. Preventive therapy for tuberculosis infection: an intervention in need of improvement. Am Rev Respir Dis 1984;130:355-356
    Web of Science | Medline

  21. 21

    Sumartojo E. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am Rev Respir Dis 1993;147:1311-1320
    Web of Science | Medline

  22. 22

    Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:Suppl:S221-S247
    Web of Science | Medline

  23. 23

    Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations -- United States, 2001. Am J Respir Crit Care Med 2001;164:1319-1320
    Web of Science

Citing Articles (59)

Citing Articles

  1. 1

    D.K. Moonan, . (2012) Using Genotyping and Geospatial Scanning to Estimate Mycobacterium tuberculosis Transmission. Emerging Infectious Diseases 18:3,
    CrossRef

  2. 2

    Satoshi Kato, N. Kawahara, H. Murakami, S. Demura, K. Yoshioka, H. Okamoto, K. Tomita, H. Tsuchiya. (2011) Extensive thoracolumbar spinal tuberculosis treated with two-stage surgery using a minimally invasive posterior instrumentation. ArgoSpine News & Journal 23:4, 171-173
    CrossRef

  3. 3

    Smita Ghosh, Patrick Moonan, Lauren Cowan, Juliana Grant, Steven Kammerer, Thomas Navin. (2011) Tuberculosis Genotyping Information Management System: Enhancing Tuberculosis Surveillance in the United States. Infection, Genetics and Evolution
    CrossRef

  4. 4

    Satoshi Kato, Norio Kawahara, Hideki Murakami, Satoru Demura, Katsuhito Yoshioka, Yoshiyuki Okamoto, Katsuro Tomita, Hiroyuki Tsuchiya. (2011) Extensive thoracolumbar spinal tuberculosis treated with two-stage surgery using a minimally invasive posterior instrumentation. European Journal of Orthopaedic Surgery & Traumatology 21:6, 407-409
    CrossRef

  5. 5

    Scott A. Weisenberg, Andrea L. Gibson, Richard C. Huard, Natalia Kurepina, Heejung Bang, Luiz C.O. Lazzarini, Yalin Chiu, Jiehui Li, Shama Ahuja, Jeff Driscoll, Barry N. Kreiswirth, John L. Ho. (2011) Distinct clinical and epidemiological features of tuberculosis in New York City caused by the RDRio Mycobacterium tuberculosis sublineage. Infection, Genetics and Evolution
    CrossRef

  6. 6

    M. W. Borgdorff, S. van den Hof, N. Kalisvaart, K. Kremer, D. van Soolingen. (2011) Influence of Sampling on Clustering and Associations With Risk Factors in the Molecular Epidemiology of Tuberculosis. American Journal of Epidemiology 174:2, 243-251
    CrossRef

  7. 7

    M. L. Wieland, J. A. Weis, M. W. Olney, M. Aleman, S. Sullivan, K. Millington, C. O'Hara, J. A. Nigon, I. G. Sia. (2011) Screening for Tuberculosis at an Adult Education Center: Results of a Community-Based Participatory Process. American Journal of Public Health 101:7, 1264-1267
    CrossRef

  8. 8

    C. M. Denkinger, K. Dheda, M. Pai. (2011) Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion?. Clinical Microbiology and Infection 17:6, 806-814
    CrossRef

  9. 9

    Jianhong Wu, Hongbin Guo. (2011) Persistent high incidence of tuberculosis among immigrants in a low-incidence country: Impact of immigrants with early or late latency. Mathematical Biosciences and Engineering 8:3, 695-709
    CrossRef

  10. 10

    Jordan A. Kempker, Francisco J. Pasquel, Maria S. Castejon, Anna Acosta, Elisa Zaragoza-Macias, Nurcan Ilksoy, Stacy Higgins, Ildefonso Tellez. (2011) Quality Improvement of Tuberculosis Screening in Foreign-Born Patients. Journal of Immigrant and Minority Health
    CrossRef

  11. 11

    Horsburgh, C. Robert Jr., Rubin, Eric J., . (2011) Latent Tuberculosis Infection in the United States. New England Journal of Medicine 364:15, 1441-1448
    Full Text

  12. 12

    I. G. Sia, M. L. Wieland. (2011) Current Concepts in the Management of Tuberculosis. Mayo Clinic Proceedings 86:4, 348-361
    CrossRef

  13. 13

    Miguel Santín Cerezales, Enrique Navas Elorza. (2011) Tuberculosis in special populations. Enfermedades Infecciosas y Microbiología Clínica 29, 20-25
    CrossRef

  14. 14

    Paul W. Colson, Julie Franks, Rita Sondengam, Yael Hirsch-Moverman, Wafaa El-Sadr. (2010) Tuberculosis Knowledge, Attitudes, and Beliefs in Foreign-born and US-born Patients with Latent Tuberculosis Infection. Journal of Immigrant and Minority Health 12:6, 859-866
    CrossRef

  15. 15

    Mark L. Wieland, Jennifer A. Weis, Barbara P. Yawn, Susan M. Sullivan, Kendra L. Millington, Christina M. Smith, Susan Bertram, Julie A. Nigon, Irene G. Sia. (2010) Perceptions of Tuberculosis Among Immigrants and Refugees at an Adult Education Center: A Community-Based Participatory Research Approach. Journal of Immigrant and Minority Health
    CrossRef

  16. 16

    S Haney, SC Stenton. (2010) Tuberculosis and the older patient. Reviews in Clinical Gerontology 20:02, 81-91
    CrossRef

  17. 17

    D. Lopez de Castilla, N.W. Schluger. (2009) Tuberculosis following solid organ transplantation. Transplant Infectious Diseaseno-no
    CrossRef

  18. 18

    A. Tardin, M. Dominicé Dao, B. Ninet, J.-P. Janssens. (2009) Tuberculosis cluster in an immigrant community: case identification issues and a transcultural perspective. Tropical Medicine & International Health 14:9, 995-1002
    CrossRef

  19. 19

    N. Alonso Rodríguez, F. Chaves, J. Iñigo, E. Bouza, D. García de Viedma, , S. Andrés, R. Cías, R. Daza, D. Domingo, J. Esteban, J. García, E. Gómez Mampaso, M. Herranz, E. Palenque, M. J. Ruiz Serrano. (2009) Transmission permeability of tuberculosis involving immigrants, revealed by a multicentre analysis of clusters. Clinical Microbiology and Infection 15:5, 435-442
    CrossRef

  20. 20

    G.D. van der Spuy, K. Kremer, S.L. Ndabambi, N. Beyers, R. Dunbar, B.J. Marais, P.D. van Helden, R.M. Warren. (2009) Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis 89:2, 120-125
    CrossRef

  21. 21

    Jacqueline M. Achkar, Tsering Sherpa, Hillel W. Cohen, Robert S. Holzman. (2008) Differences in Clinical Presentation among Persons with Pulmonary Tuberculosis: A Comparison of Documented and Undocumented Foreign‐Born versus US‐Born Persons. Clinical Infectious Diseases 47:10, 1277-1283
    CrossRef

  22. 22

    Kevin P. Cain, William R. Mac Kenzie, Kenneth G. Castro, Philip A. LoBue. (2008) Editorial Commentary: No Man Is an Island: Reducing Diagnostic Delays in Undocumented Foreign‐Born Persons Is Needed to Decrease the Risk of Tuberculosis Transmission. Clinical Infectious Diseases 47:10, 1284-1286
    CrossRef

  23. 23

    A. Thomas Pezzella, Wentao Fang. (2008) Surgical Aspects of Thoracic Tuberculosis: A Contemporary Review—Part 1. Current Problems in Surgery 45:10, 675-758
    CrossRef

  24. 24

    Miguel Martínez‐Lirola, Noelia Alonso‐Rodriguez, M. Luisa Sánchez, Marta Herranz, Sandra Andrés, Teresa Peñafiel, M. Cruz Rogado, Teresa Cabezas, Juan Martínez, M. Ángeles Lucerna, Manuel Rodríguez, Magdalena del Carmen Bonillo, Emilio Bouza, Darío García de Viedma. (2008) Advanced Survey of Tuberculosis Transmission in a Complex Socioepidemiologic Scenario with a High Proportion of Cases in Immigrants. Clinical Infectious Diseases 47:1, 8-14
    CrossRef

  25. 25

    Z JIA, G TANG, Z JIN, C DYE, S VLAS, X LI, D FENG, L FANG, W ZHAO, W CAO. (2008) Modeling the impact of immigration on the epidemiology of tuberculosis. Theoretical Population Biology 73:3, 437-448
    CrossRef

  26. 26

    K. P. Cain, W. R. Mac Kenzie. (2008) Overcoming the Limits of Tuberculosis Prevention among Foreign-Born Individuals: Next Steps toward Eliminating Tuberculosis. Clinical Infectious Diseases 46:1, 107-109
    CrossRef

  27. 27

    Eui Ju Park, Yang-Ki Kim, Jin Hyun Bok, Young Mok Lee, Ki-Up Kim, Soo-taek Uh, Young-Kil Park. (2008) Use of Molecular Identification Analysis in a Case of Intra-familial Transmission of Tuberculosis. Tuberculosis and Respiratory Diseases 65:6, 512
    CrossRef

  28. 28

    N. D. Walter, R. M. Jasmer, J. Grinsdale, L. M. Kawamura, P. C. Hopewell, P. Nahid. (2008) Reaching the Limits of Tuberculosis Prevention among Foreign-Born Individuals: A Tuberculosis-Control Program Perspective. Clinical Infectious Diseases 46:1, 103-106
    CrossRef

  29. 29

    Ángel Domínguez-Castellano, Alfonso del Arco, Jesús Canueto-Quintero, Antonio Rivero-Román, José María Kindelán, Ricardo Creagh, Felipe Díez-García. (2007) Guía de práctica clínica de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI) sobre el tratamiento de la tuberculosis. Enfermedades Infecciosas y Microbiología Clínica 25:8, 519-534
    CrossRef

  30. 30

    Vitali Sintchenko, Gwendolyn L. Gilbert. (2007) Utility of genotyping of Mycobacterium tuberculosis in the contact investigation: A decision analysis. Tuberculosis 87:3, 176-184
    CrossRef

  31. 31

    Inna Vitol, Jeffrey Driscoll, Barry Kreiswirth, Natalia Kurepina, Kristin P. Bennett. (2006) Identifying Mycobacterium tuberculosis complex strain families using spoligotypes. Infection, Genetics and Evolution 6:6, 491-504
    CrossRef

  32. 32

    Fergus P. MCCARTHY, Shelley ROWLANDS, Michelle GILES. (2006) Tuberculosis in pregnancy – Case studies and a review of Australia's screening process. The Australian and New Zealand Journal of Obstetrics and Gynaecology 46:5, 451-455
    CrossRef

  33. 33

    F.J. Candel, M. Matesanz, R. Cías, I. Candel, V. Roca-Arbonés, J.J. Picazoa. (2006) Impacto de la tuberculosis en Madrid: análisis de parámetros clínicos y epidemiológicos en un Hospital General durante 2002. Revista Clínica Española 206:8, 414-415
    CrossRef

  34. 34

    H. Akan, Ö. Arslan, Ö.A. Akan. (2006) Tuberculosis in stem cell transplant patients. Journal of Hospital Infection 62:4, 421-426
    CrossRef

  35. 35

    Dolores Lagares-Serrano, José Ignacio Mora-Arias. (2006) Morbilidad en inmigrantes subsaharianos mayores de 60 años. Revista Española de Geriatría y Gerontología 41:2, 92-99
    CrossRef

  36. 36

    Judith E. Sackoff, Melissa R. Pfeiffer, Cynthia R. Driver, Lynda S. Streett, Sonal S. Munsiff, Jack A. DeHovitz. (2006) Tuberculosis prevention for non–US-born pregnant women. American Journal of Obstetrics and Gynecology 194:2, 451-456
    CrossRef

  37. 37

    Óscar Sanz-Peláez, José A. Caminero-Luna, José L. Pérez-Arellano. (2006) Tuberculosis e inmigración en España. Evidencias y controversias. Medicina Clínica 126:7, 259-269
    CrossRef

  38. 38

    Masashi Kizuki, Takehito Takano, Keiko Nakamura, Yoshiharu Fukuda, Masafumi Watanabe, Tomoko Inose, Kaoruko Seino, Yoshiko Kawabe. (2006) Social Course Patterns of Urban Dwellers with Tuberculosis under Fragile Living Conditions in Tokyo, Japan. Journal of Epidemiology 16:4, 167-175
    CrossRef

  39. 39

    Young Kil Park, Hee Yeun Kang, Jang Geun Lim, Jong Sik Ha, Jung Ok Cho, Ka Chel Lee, Hang Soon Choi, Young Hwa Choi, Seung Soo Sheen, Gill Han Bai. (2006) Analysis of DNA fingerprints of Mycobacterium Tuberculosis Isolates from Patients Registered at Health Center in Gyeonggi Province in 2004. Tuberculosis and Respiratory Diseases 60:3, 290
    CrossRef

  40. 40

    Richard Frothingham, Jason E. Stout, Carol Dukes Hamilton. (2005) Current issues in global tuberculosis control. International Journal of Infectious Diseases 9:6, 297-311
    CrossRef

  41. 41

    E. García-Pachón, J.C. Rodríguez. (2005) Epidemiología molecular de la tuberculosis: principales hallazgos y su aplicación en España. Archivos de Bronconeumología 41:11, 618-624
    CrossRef

  42. 42

    A. Ustianowski, R. Shaffer, S. Collin, R.J. Wilkinson, R.N. Davidson. (2005) Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. Journal of Infection 50:5, 432-437
    CrossRef

  43. 43

    Charles L. Daley. (2005) Molecular Epidemiology: A Tool for Understanding Control of Tuberculosis Transmission. Clinics in Chest Medicine 26:2, 217-231
    CrossRef

  44. 44

    Aeesha NJ Malik, Peter Godfrey-Faussett. (2005) Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. The Lancet Infectious Diseases 5:3, 174-183
    CrossRef

  45. 45

    Suhail Ahmad, Esther Fares. (2005) Genotypic Diversity among Isoniazid-Resistant Isolates of <i>Mycobacterium tuberculosis</i> from Rashid Hospital in Dubai, United Arab Emirates. Medical Principles and Practice 14:1, 16-21
    CrossRef

  46. 46

    F. M. Gany, C. Trinh-Shevrin, J. Changrani. (2005) Drive-by Readings: A Creative Strategy for Tuberculosis Control Among Immigrants. American Journal of Public Health 95:1, 117-119
    CrossRef

  47. 47

    Linh N. NGUYEN, Gwendolyn L. GILBERT, Guy B. MARKS. (2004) Molecular epidemiology of tuberculosis and recent developments in understanding the epidemiology of tuberculosis. Respirology 9:3, 313-319
    CrossRef

  48. 48

    Suhail Ahmad, Eiman Mokaddas. (2004) Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East. International Journal of Antimicrobial Agents 23:5, 473-479
    CrossRef

  49. 49

    L. Aaron, D. Saadoun, I. Calatroni, O. Launay, N. Memain, V. Vincent, G. Marchal, B. Dupont, O. Bouchaud, D. Valeyre, O. Lortholary. (2004) Tuberculosis in HIV-infected patients: a comprehensive review. Clinical Microbiology and Infection 10:5, 388-398
    CrossRef

  50. 50

    William F Paolo, Joshua D Nosanchuk. (2004) Tuberculosis in New York city: recent lessons and a look ahead. The Lancet Infectious Diseases 4:5, 287-293
    CrossRef

  51. 51

    William S. Mow, Maria T. Abreu-martin, Konstantinos A. Papadakis, Howard E. Pitchon, Stephan R. Targan, Eric A. Vasiliauskas. (2004) High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. Clinical Gastroenterology and Hepatology 2:4, 309-313
    CrossRef

  52. 52

    Thomas P. Giordano, Hanna Soini, Larry D. Teeter, Gerald J. Adams, James M. Musser, Edward A. Graviss. (2004) Relating the Size of Molecularly Defined Clusters of Tuberculosis to the Duration of Symptoms. Clinical Infectious Diseases 38:1, 10-16
    CrossRef

  53. 53

    Mari HOTTA, Eri NAGASHIMA, Sachiko TAKAGI, Ichiro ITODA, Takanori NUMATA, Nobuyuki KOBAYASHI, Kazue TAKANO. (2004) Two Young Female Patients with Anorexia Nervosa Complicated by Mycobacterium Tuberculosis Infection. Internal Medicine 43:5, 440-444
    CrossRef

  54. 54

    Laura S. Inselman. (2003) Tuberculin Skin Testing and Interpretation in Children. Pediatric Asthma, Allergy & Immunology 16:4, 225-235
    CrossRef

  55. 55

    Jennifer A. LaRosa, Michael Cutaia. (2003) Urban tuberculosis: The new face of an old problem. Current Infectious Disease Reports 5:3, 246-253
    CrossRef

  56. 56

    Khan, Kamran, Muennig, Peter, Behta, Maryam, Zivin, Joshua Graff, . (2002) Global Drug-Resistance Patterns and the Management of Latent Tuberculosis Infection in Immigrants to the United States. New England Journal of Medicine 347:23, 1850-1859
    Full Text

  57. 57

    Howard Markel, Alexandra Minna Stern. (2002) The Foreignness of Germs: The Persistent Association of Immigrants and Disease in American Society. Milbank Quarterly 80:4, 757-788
    CrossRef

  58. 58

    (2002) Changes in the Transmission of Tuberculosis in New York. New England Journal of Medicine 347:18, 1453-1455
    Full Text

  59. 59

    Bloom, Barry R., . (2002) Tuberculosis — The Global View. New England Journal of Medicine 346:19, 1434-1435
    Full Text

Letters